Back
Stuart H. Orkin
Boston Children’s Hospital, Dana Farber Cancer Institute, Harvard Medical School, and Howard Hughes Medical Institute
2026 Breakthrough Prize in Life Sciences
For elucidating the mechanism driving the switch from fetal to adult hemoglobin and validating it as a therapeutic target for sickle-cell disease and beta-thalassemia.